Nintedanib Plus EGFR TKI In EGFR-mutated Non-small Cell Lung Cancer Patients
Clinical trial NCT06071013 · RECRUITING
Trial details
- NCT number
- NCT06071013
- Sponsor
- China Medical University Hospital
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-23
- Primary completion
- 2026-08-27
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.